Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice
Yasuhiro Ishihara, Koji Ohmori, Mizuki Mizukawa, et al.
Atherosclerosis (2010) Vol. 212, Iss. 1, pp. 131-138
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Statin treatment and new-onset diabetes: A review of proposed mechanisms
Marilyne Brault, Jessica Ray, Yessica-Haydee Gomez, et al.
Metabolism (2014) Vol. 63, Iss. 6, pp. 735-745
Closed Access | Times Cited: 211
Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products
Jelena Jakab, Blaženka Miškić, Štefica Mikšić, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 67-83
Open Access | Times Cited: 188
Association between triglyceride glucose index and all-cause mortality in patients with cerebrovascular disease: a retrospective study
Yong’An Jiang, Peng Chen, Yangyang Zhao, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Relationship between Epicardial and Coronary Adipose Tissue and the Expression of Adiponectin, Leptin, and Interleukin 6 in Patients with Coronary Artery Disease
О. В. Груздева, Yu. A. Dyleva, E. V. Belik, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 129-129
Open Access | Times Cited: 30
Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
Sofia Dias, Sílvia Paredes, Laura Ribeiro
International Journal of Endocrinology (2018) Vol. 2018, pp. 1-21
Open Access | Times Cited: 45
Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: The COMPACT-CAD study
Kazumasa Kurogi, Seigo Sugiyama, Kenji Sakamoto, et al.
Journal of Cardiology (2013) Vol. 62, Iss. 2, pp. 87-94
Open Access | Times Cited: 42
Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer’s disease
Tomoko Kurata, Kazunori Miyazaki, Nobutoshi Morimoto, et al.
Neurological Research (2013) Vol. 35, Iss. 2, pp. 193-205
Closed Access | Times Cited: 41
Transgenic ω-3 PUFA enrichment alters morphology and gene expression profile in adipose tissue of obese mice: Potential role for protectins
Phillip J. White, Patricia L. Mitchell, Michael Schwab, et al.
Metabolism (2015) Vol. 64, Iss. 6, pp. 666-676
Closed Access | Times Cited: 40
Comparison of effects of pitavastatin and atorvastatin on glucose metabolism in type 2 diabetic patients with hypercholesterolemia
Tomoya Mita, Shiho Nakayama, Hiroko Abe, et al.
Journal of Diabetes Investigation (2013) Vol. 4, Iss. 3, pp. 297-303
Open Access | Times Cited: 37
Pathogenesis and Management of the Diabetogenic Effect of Statins: a Role for Adiponectin and Coenzyme Q10?
Dick C. Chan, Jing Pang, Gerald F. Watts
Current Atherosclerosis Reports (2014) Vol. 17, Iss. 1
Closed Access | Times Cited: 34
Statins and their increased risk of inducing diabetes
Aris P. Agouridis, Michael S. Kostapanos, Moses Elisaf
Expert Opinion on Drug Safety (2015) Vol. 14, Iss. 12, pp. 1835-1844
Closed Access | Times Cited: 32
Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance (the J-PREDICT study): rationale, study design, and clinical characteristics of 1269 patients
Tsutomu Yamazaki, Junji Kishimoto, Chikako Ito, et al.
Diabetology International (2011) Vol. 2, Iss. 3, pp. 134-140
Closed Access | Times Cited: 30
Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes
Tracey G. Simon
World Journal of Gastroenterology (2015) Vol. 21, Iss. 27, pp. 8293-8293
Open Access | Times Cited: 25
Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
Kouji Kajinami, Kawai Yasusyuki
Drug Design Development and Therapy (2011), pp. 283-283
Open Access | Times Cited: 28
Enhancement of antioxidant defense mechanism by pitavastatin and rosuvastatin on obesity-induced oxidative stress in Wistar rats
Javed Akhtar Ansari, Uma Bhandari, Syed Ehtaishamul Haque, et al.
Toxicology Mechanisms and Methods (2011) Vol. 22, Iss. 1, pp. 67-73
Closed Access | Times Cited: 21
PPARγ activation mitigates glucocorticoid receptor‐induced excessive lipolysis in adipocytes via homeostatic crosstalk
Arif Ul Hasan, Koji Ohmori, Takeshi Hashimoto, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 6, pp. 4627-4635
Open Access | Times Cited: 19
Pitavastatin – from clinical trials to clinical practice
L. Masana
Atherosclerosis Supplements (2010) Vol. 11, Iss. 3, pp. 15-22
Closed Access | Times Cited: 21
Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat
Hiromi Kawai, Shoko Deguchi, Kentaro Deguchi, et al.
Brain Research (2011) Vol. 1382, pp. 308-314
Closed Access | Times Cited: 16
Haemostatic risk factors in dyslipidemic rabbits: role of 10-dehydrogingerdione as a new hypolipemic agent
Mohamed M. Elseweidy, Mervat E. Asker, Sameih El-Dahmy, et al.
Journal of Thrombosis and Thrombolysis (2014) Vol. 39, Iss. 2, pp. 196-202
Closed Access | Times Cited: 15
Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes
Manal Elfakhani, Sheida Torabi, Deema Hussein, et al.
Experimental Biology and Medicine (2014) Vol. 239, Iss. 3, pp. 293-301
Closed Access | Times Cited: 13
Atorvastatin delays the glucose clearance rate in hypercholesterolemic rabbits
Daxin Cheng, Yanli Wang, Shoucui Gao, et al.
Biomedicine & Pharmacotherapy (2015) Vol. 72, pp. 24-29
Closed Access | Times Cited: 12
Pitavastatin and carbohydrate metabolism: what is the evidence?
Theodosios D. Filippatos, Moses Elisaf
Expert Review of Clinical Pharmacology (2016) Vol. 9, Iss. 7, pp. 955-960
Closed Access | Times Cited: 12
Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet
Yoshihiro Kamada, Shinichi Kiso, Yuichi Yoshida, et al.
Hepatology Research (2012) Vol. 43, Iss. 4, pp. 401-412
Closed Access | Times Cited: 11
Pioglitazone promotes preadipocyte proliferation by downregulating p16Ink4a
Arif Ul Hasan, Koji Ohmori, Takeshi Hashimoto, et al.
Biochemical and Biophysical Research Communications (2011) Vol. 411, Iss. 2, pp. 375-380
Closed Access | Times Cited: 10
Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, <i>in vitro</i> and <i>in vivo </i>
Yongin Cho, Hyangkyu Lee, Hyun Ki Park, et al.
Journal of Atherosclerosis and Thrombosis (2019) Vol. 27, Iss. 5, pp. 429-440
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top